SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of Options Outstanding and Vested, Balance	321,770
Number of Options Outstanding and Vested, Balance			321,770
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of Options Outstanding and Vested, Balance	321,759		406,270
Weighted Average Exercise Price, Outstanding and vested, Balance	$ 12.8634		$ 11.4750
Weighted Average Contractual Life (Years)	1 year 3 months 18 days		1 year 11 months 19 days
Aggregated Intrinsic Value, Balance
Number of Options Outstanding and Vested, Warrants issued	241,446	[1]	69,730	[2]
Weighted Average Exercise Price, Warrants issued	$ 8.5677	[1]	$ 5.1090	[2]
Number of Options Outstanding and Vested, Warrants exercised	(507,444)	[3]	(154,230)	[4]
Weighted Average Exercise Price, Warrants exercised	$ 8.2857	[3]	$ 5.7008	[4]
Number of Options Outstanding and Vested, Balance	55,761		321,759
Weighted Average Exercise Price, Outstanding and vested, Balance	$ 10.6087		$ 12.8634
Weighted Average Contractual Life (Years)	1 year 4 months 2 days		1 year 3 months 18 days
Aggregated Intrinsic Value, Balance	$ 1,152,654

[1] The warrants issued in the year ended December 31, 2023 had a total grant date fair value of $2,158,116.

[2] The warrants issued in the year ended December 31, 2022 had a total grant date fair value of $853,397.

[3] During the year ended December 31, 2023, warrant holders exercised a total 507,444 warrants to purchase 446,948 shares of the Company’s common stock. The warrant exercises were executed with exercise prices ranging between $5.1085 and $15.00 per share and were paid for with (i) $1,774,608 in cash proceeds to the Company and (ii) 60,496 warrants conceded in cashless exercises. As a result of the warrants exercised, the Company issued 446,948 shares of common stock.

[4] During the year ended December 31, 2022, warrant holders exercised a total 154,230 warrants to purchase 135,631 shares of the Company’s common stock. The warrant exercises were executed with exercise prices ranging between $4.3125 and $8.025 per share and were paid for with (i) $600,159 in cash proceeds to the Company and (ii) 18,610 warrants conceded in cashless exercises. As a result of the warrants exercised, the Company issued 135,631 shares of common stock.